In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Specialty Pharma: Tapping Japan

Executive Summary

Economic recovery, pharmaceutical consolidation, and a burgeoning private equity sector have encouraged a new cluster of Japan-focused specialty pharmas
Advertisement

Related Content

Best of the Blog: IN VIVO, June 2008
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2007
Europe's New Spec Pharma Models
The Rise of Regional Dealmaking
The Rise of Regional Dealmaking
Trade Sales Trump IPOs, Even for Platforms
Bayer: Out of Trouble Come Opportunities
Bayer: Out of Trouble Come Opportunities
European Players Wake Up to Japanese Opportunities
Sosei's Drug Re-Profiling Strategy: A Three-Way Street

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002856

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel